What is driving ALNA stock volume today?

ALNA stock volume is driven by intraday momentum and retail interest; the stock traded **252,311,606** shares today. Microcap biotech names often spike on speculation or small news items, so check company releases and clinical calendars.

What are the key valuation metrics for ALNA?

ALNA shows EPS **-0.64**, trailing P/E **-0.12**, cash per share **$0.92**, and current ratio **2.11**. These metrics reflect a development-stage biotech with negative earnings and limited revenue.

How does Meyka AI grade ALNA stock?

Meyka AI rates ALNA with a score out of 100: **62.59 | Grade B | Suggestion: HOLD**. This grade factors S&P benchmark, sector, financial growth, key metrics, forecasts, and analyst consensus.

What price target does Meyka AI give for ALNA?

Meyka AI's forecast model projects a 12-month base-case price of **$0.18**, a bear case **$0.04**, and a bull case **$0.40**. Forecasts are model-based projections and not guarantees.

US Stocks

ALNA Allena Pharmaceuticals NASDAQ Intraday 12 Feb 2026: Volume up at $0.075

ByHuzaifa Zahoor February 12, 2026February 12, 2026

ALNA stock is trading at $0.075 on the NASDAQ intraday session on 12 Feb 2026, reflecting a +3.16% move as volume spikes to 252,311,606 shares. This makes Allena Pharmaceuticals, Inc. (ALNA) one of the most active small-cap names today in the United States healthcare tape. Traders are reacting to heavy intraday swings between a day low $0.06 and a day high $0.146, while fundamentals show a small cash runway and negative EPS. We use real-time data and Meyka AI’s market tools to connect the trading activity to valuation and near-term catalysts.